Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.380
-0.140 (-5.56%)
Sep 8, 2025, 4:00 PM - Market closed
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $169.71 million as of September 8, 2025. Its market cap has increased by 22.53% in one year.
Market Cap
169.71M
Enterprise Value
-23.25M
1-Year Change
22.53%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $169.71M, a decrease of -78.32%. That is a compound annual growth rate of -32.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 179.70M | 16.04% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |